102. Rubinstein-Taybi syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 3 / Drugs : 5 - (DrugBank : 1) / Drug target genes : 7 - Drug target pathways : 17
Drugs and their primary sponsors and trial info
Culture of lymphoblastoid line from blood sample
University Hospital, Bordeaux
2019 - NCT04122742 France;
Depakine
CHU de bordeaux
- Phase 2 EUCTR2011-003784-30-FR France;
Skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 SRT patients included.
University Hospital, Bordeaux
2019 - NCT04122742 France;
Sodium valproate
University Hospital, Bordeaux
2012 Phase 2 NCT01619644 France;
University Hospital, Bordeaux
2019 - NCT04122742 France;
Depakine
CHU de bordeaux
- Phase 2 EUCTR2011-003784-30-FR France;
Skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 SRT patients included.
University Hospital, Bordeaux
2019 - NCT04122742 France;
Sodium valproate
University Hospital, Bordeaux
2012 Phase 2 NCT01619644 France;